**Source:** `agentic-ai-the-new-frontier-in-genai-an-executive-playbook`

**Insilico Medicine: AI for Drug Discovery**
Insilico Medicine has developed inClinico, an AI platform that predicts phase II clinical trial outcomes to enhance drug discovery and development, yielding a 35% nine-month ROI in an investment application and reducing drug development time.
